Understanding Chronic Lymphocytic Leukemia

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT04028531
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

Key Dates

Start date
Sep 29, 1999
Status verified
Apr 2026
Primary completion
Sep 29, 2030
Completion
Sep 29, 2032

Study Design

Enrollment
2,750 participants (estimated)

Arms

  • Arm: Sample Collection
    * Blood tests required for assessment * Specimens and data will also be collected from outside sites * Clinical data from patients with Chronic Lymphocytic Leukemia will be gathered into a database at Dana Farber Cancer Institute

Primary Outcome Measure

Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia [ Time Frame: 20 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dana Farber Cancer InstituteBostonMassachusetts02115
Jennifer Brown, MD, PhD
[email protected]
617-582-8437
Jennifer Brown, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
Dana Farber Cancer Institute· Boston, MA

Related Studies